You are here:

74. Nielsen MB, Laurberg S, Holm T. Current management of locally recurrent rectal cancer. Colorectal Dis. 2011 Jul;13(7):732-42.

73. Offersen BV, Brodersen HJ, Nielsen MM, Overgaard J, Overgaard M. Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1-3 Positive Lymph Nodes? Breast Care (Basel). 2011 Oct;6(5):347-351.

71. Keall PJ, Sawant A, Cho B, Ruan D, Wu J, Poulsen P, Petersen J, Newell LJ, Cattell H, Korreman S. Electromagnetic-guided dynamic multileaf collimator tracking enables motion management for intensity-modulated arc therapy. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):312-20.

69. Hansen AE, Kristensen AT, Law I, Jørgensen JT, McEvoy FJ, Busk M, van der Kogel AJ, Bussink J, Kjær A, Engelholm SA. Initial non-invasive and invasive experiences using [64Cu]ATSM in spontaneous canine tumors. Cancer Imaging. 2011 Oct 3;11 Spec No A:S42-3.

68. Høyer M, Thor M, Thörnqvist S, Søndergaard J, Lassen-Ramshad Y, Paul Muren L. Advances in radiotherapy: from 2D to 4D. Cancer Imaging. 2011 Oct 3;11 Spec No A:S147-52.

67. Fledelius W, Worm E, Elstro̸m UV, Petersen JB, Grau C, Ho̸yer M, Poulsen PR. Robust automatic segmentation of multiple implanted cylindrical gold fiducial markers in cone-beam CT projections. Med Phys. 2011 Dec;38(12):6351.

66. Wojdacz TK, Thestrup BB, Overgaard J, Hansen LL. Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events. Diagn Pathol. 2011 Nov 30;6(1):116.

64. Schmitz T, Blaickner M, Ziegner M, Bassler N, Grunewald C, Kratz JV, Schütz C, Langguth P, Sharpe P, Palmans H, Holzscheiter MH, Otto G, Hampel G. Dose determination using alanine detectors in a mixed neutron and gamma field for boron neutron capture therapy of liver malignancies. Acta Oncol. 2011 Aug;50(6):817-22.

63. Hysing LB, Söhn M, Muren LP, Alber M. A coverage probability based method to estimate patient-specific small bowel planning volumes for use in radiotherapy. Radiother Oncol. 2011 Sep;100(3):407-11.

62. Busk M, Bohn AB, Skals M, Wang T, Horsman MR. Combretastatin-induced hypertension and the consequences for its combination with other therapies. Vascul Pharmacol. 2011 Jan-Feb;54(1-2):13-7.

61. Bertelsen LB, Shen YY, Nielsen T, Stødkilde-Jørgensen H, Lloyd GK, Siemann DW, Horsman MR. Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation. Int J Radiat Biol. 2011 Nov;87(11):1126-34.

60. Waldeland E, Helt-Hansen J, Malinen E Characterization of lithium formate EPR dosimeters for high dose applications – Comparison with alanine Radiation Measurements 46:213-8, 2011.

59. Rosenschöld PM, Engelholm S, Ohlhues L, Law I, Vogelius I, Engelholm SA. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking. Acta Oncol. 2011 Aug;50(6):777-83.

58. Lühr A, Hansen DC, Sobolevsky N, Palmans H, Rossomme S, Bassler N. Fluence correction factors and stopping power ratios for clinical ion beams. Acta Oncol. 2011 Aug;50(6):797-805.

57. Haack S, Jespersen SN, Fokdal L, Lindegaard JC, Kallehauge JF, Tanderup K, Pedersen EM. Diffusion Weighted MRI (DWI) for brachytherapy in locally advanced cervical cancer – determining the degree of distortion at 1.5T and 3T MRI. IFMBE Proceedings 34, pp. 172-175, 2011.

55. Noe KØ, Tanderup K, Sørensen TS Surface membrane based bladder registration for evaluation of accumulated dose during brachytherapy in cervical cancer IEEE International Symposium on Biomedical Imaging (ISBI) 2011. 4 pp. 1253-1256.

54. Kertzscher G , Andersen CE , Siebert F-A , Nielsen SK ,Lindegaard JC, Tanderup K Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al2O3:C dosimetry and a novel statistical error decision criterion Radiother Oncol. 2011 Sep;100(3):456-62.

53. Yates ES, Balling P, Petersen JB, Christensen MN, Skyt PS, Bassler N, Kaiser FJ, Muren LP. Characterization of the optical properties and stability of Presage™ following irradiation with photons and carbon ions. Acta Oncol. 2011 Aug;50(6):829-34.

52. Lassen-Ramshad Y, Vestergaard A, Muren LP, Høyer M, Petersen JB. Plan robustness in proton beam therapy of a childhood brain tumour. Acta Oncol. 2011 Aug;50(6):791-6.

51. Andersen CE, Damkjær SMS, Kertzscher G, Greilich S, and Aznar MC Fiber-coupled radioluminescence dosimetry with saturated Al2O3:C crystals: Characterization in 6 and 18 MV photon beams Radiation Measurements 46 (2011) 1090-1098

50. Kertzscher G, Andersen CE, Edmund JM, and Tanderup K Stem signal suppression in fiber-coupled Al2O3:C dosimetry for 192 Ir brachytherapy Radiation Measurements 46:2020-24, 2011.

49. Havelund BM, Sørensen FB, Lindebjerg J, Spindler KL, Jakobsen A. Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer. Anticancer Res. 2011 May;31(5):1559-65.

48. Gonzalez-Angulo AM, Hennessy BT, Meric-Bernstam F, Sahin A, Liu W, Ju Z, Carey MS, Myhre S, Speers C, Deng L, Broaddus R, Lluch A, Aparicio S, Brown P, Pusztai L, Symmans WF, Alsner J, Overgaard J, Borresen-Dale AL, Hortobagyi GN, Coombes KR, Mills GB. Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer. Clin Proteomics. 2011 Jul 8;8(1):11.

47. Fokdal L, Tanderup K, Nielsen SK, Christensen HK, Røhl L, Pedersen EM, Schønemann NK, Lindegaard JC. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Radiother Oncol. 2011 Sep;100(3):473-9.

46. Offersen B, Højris I, Overgaard M. Radiation-induced heart morbidity after adjuvant radiotherapy of early breast cancer - Is it still an issue? Radiother Oncol. 2011 Aug;100(2):157-9.

45. Thor M, Petersen JB, Bentzen L, Høyer M, Muren LP. Deformable image registration for contour propagation from CT to cone-beam CT scans in radiotherapy of prostate cancer. Acta Oncol. 2011 Aug;50(6):918-25.

44. Thörnqvist S, Bentzen L, Petersen JB, Hysing LB, Muren LP. Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques. Acta Oncol. 2011 Aug;50(6):926-34.

43. Skyt PS, Balling P, Petersen JB, Yates ES, Muren LP. Temperature dependence of the dose response for a solid-state radiochromic dosimeter during irradiation and storage Med Phys. 2011 May;38(5):2806-11

42. Bertelsen A, Schytte T, Bentzen SM, Hansen O, Nielsen M, Brink C. Radiation dose response of normal lung assessed by Cone Beam CT - A potential tool for biologically adaptive radiation therapy Radiother Oncol. 2011 Sep;100(3):351-5.

41. Bertelsen A, Lorenzen EL, and Brink C Validation of a new control system for Elekta accelerators facilitating continuously variable dose rate Med Phys. 2011 Aug;38(8):4802-10.

40. Ravkilde T, Keall PJ, Højbjerre K, Fledelius W, Worm E, Poulsen PR. Geometric accuracy of dynamic MLC tracking with an implantable wired electromagnetic transponder. Acta Oncol. 2011 Aug;50(6):944-51.

39. Nyeng TB, Kallehauge JF, Høyer M, Petersen JB, Poulsen PR, Muren LP. Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients. Acta Oncol. 2011 Aug;50(6):897-907.

38. Rylander S, Thörnqvist S, Haack S, Pedersen EM, Muren LP. Intensity profile based measurement of prostate gold markers influence on 1.5 and 3T diffusion-weighted MR images. Acta Oncol. 2011 Aug;50(6):866-72.

37. Fledelius W, Keall PJ, Cho B, Yang X, Morf D, Scheib S, Poulsen PR. Tracking latency in image-based dynamic MLC tracking with direct image access. Acta Oncol. 2011 Aug;50(6):952-9.

36. Baker M, Nielsen M, Hansen O, Jahn JW, Korreman S, Brink C. Isotoxic Dose Escalation in the Treatment of Lung Cancer by Means of Heterogeneous Dose Distributions in the Presence of Respiratory Motion. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):849-55.

35. Toustrup K, Sørensen BS, Nordsmark M, Busk M, Wiuf C, Alsner J, Overgaard J. Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer Cancer Res. 2011 Sep 1;71(17):5923-31.

34. Brodin NP, Rosenschöld PM, Aznar MC, Kiil-Berthelsen A, Vogelius IR, Nilsson P, Lannering B, Björk-Eriksson T. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma Acta Oncol. 2011 Aug;50(6):806-16.

33. Boejen A, Grau C. Virtual reality in radiation therapy training Surgical Oncology 20 (2011) 185-188

32. Vogelius IR, Westerly DC, Aznar MC, Cannon GM, Korreman SS, Mackie TR, Mehta MP, Bentzen SM. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer Acta Oncol. 2011 Aug;50(6):772-6.

31. D'Andrea FP, Safwat A, Kassem M, Gautier L, Overgaard J, Horsman MR. Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance Radiother Oncol. 2011 Jun;99(3):373-8.

30. Mortensen LS, Busk M, Nordsmark M, Jakobsen S, Theil J, Overgaard J, Horsman MR. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: A preclinical study Radiother Oncol. 2011 Jun;99(3):418-23.

29. Sørensen BS, Vestergaard A, Overgaard J, Præstegaard LH. Dependence of cell survival on instantaneous dose rate of a linear accelerator Radiother Oncol. 2011 Jul 5.

28. Christensen BO, Overgaard J, Kettner LO, Damsgaard TE. Long-term evaluation of postmastectomy breast reconstruction Acta Oncol. 2011 Oct;50(7):1053-61.

27. Sørensen BS, Overgaard J, Bassler N. In vitro RBE-LET dependence for multiple particle types Acta Oncol. 2011 Aug;50(6):757-62.

26. Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J. Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - Results from the randomized DAHANCA 5 and 7 trials Acta Oncol. 2011 Oct;50(7):1006-14.

25. Elstrøm UV, Muren LP, Petersen JB, Grau C. Evaluation of image quality for different kV cone-beam CT acquisition and reconstruction methods in the head and neck region Acta Oncol. 2011 Aug;50(6):908-17.

24. Petersen JB, Lassen Y, Hansen AT, Muren LP, Grau C, Høyer M. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours Acta Oncol. 2011 Aug;50(6):823-8.

23. Busk M, Walenta S, Mueller-Klieser W, Steiniche T, Jakobsen S, Horsman MR, Overgaard J. Inhibition of tumor lactate oxidation: Consequences for the tumor microenvironment. Radiother Oncol. 2011 Jun;99(3):404-11.

22. Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L. Risk factors for radiation-induced hypothyroidism: A Literature-Based Meta-Analysis. Cancer. 2011 May 12.

21. Logadóttir Á, Korreman S, Petersen PM. Comparison of the accuracy and precision of prostate localization with 2D-2D and 3D images. Radiother Oncol. 2011 Feb;98(2):175-80.

19. Poulsen PR, Fledelius W, Keall PJ, Weiss E, Lu J, Brackbill E, Hugo GD. A method for robust segmentation of arbitrarily shaped radiopaque structures in cone-beam CT projections Med Phys. 2011 Apr;38(4):2151-6.

18. Jørgensen MK, Hoffmann L, Petersen JB, Praestegaard LH, Hansen R, Muren LP. Tolerance levels of EPID-based quality control for volumetric modulated arc therapy Med Phys. 2011 Mar;38(3):1425-34.

17. Hansen AE, McEvoy F, Engelholm SA, Law I, Kristensen AT. FDG PET/CT imaging in canine cancer patients Vet Radiol Ultrasound. 2011 Mar-Apr;52(2):201-6.

16. Hansen AE, Kristensen AT, Law I, Jørgensen JT, Engelholm SA. Hypoxia-inducible factors--regulation, role and comparative aspects in tumourigenesis Vet Comp Oncol. 2011 Mar;9(1):16-37.

15. Lühr A, Hansen DC, Jäkel O, Sobolevsky N, Bassler N. Analytical expressions for water-to-air stopping-power ratios relevant for accurate dosimetry in particle therapy Phys Med Biol. 2011 Apr 21;56(8):2515-33.

14. Beierholm AR, Ottosson RO, Lindvold LR, Behrens CF, Andersen CE. Characterizing a pulse-resolved dosimetry system for complex radiotherapy beams using organic scintillators Phys Med Biol. 2011 May 21;56(10):3033-45.

13. Nielsen TB, Wieslander E, Fogliata A, Nielsen M, Hansen O, and Brink C. Influence of dose calculation algorithms on the predicted dose distributions and NTCP values for NSCLC patients Med Phys. 2011 May;38(5):2412-8.

11. Fog LS, Rasmussen JF, Aznar M, Kjær-Kristoffersen F, Vogelius IR, Engelholm SA, Bangsgaard JP. A closer look at RapidArc® radiosurgery plans using very small fields Phys Med Biol. 2011 Mar 21;56(6):1853-63.

10. Lassen P, Eriksen JG, Krogdahl A, Therkildsen MH, Ulhøi BP, Overgaard M, Specht L, Andersen E, Johansen J, Andersen LJ, Grau C, Overgaard J The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial. Radiother Oncol. 2011 Mar 21.

9. Herrmann R, Jäkel O, Palmans H, Sharpe P, Bassler N Dose response of alanine detectors irradiated with carbon ion beams Med Phys. 2011 Apr;38(4):1859-66.

8. Busk M, Toustrup K, Soerensen BS, Alsner J, Horsman MR, Jakobsen S, Overgaard J. In vivo Identification and Specificity assessment of mRNA markers of hypoxia in human and mouse tumors BMC Cancer. 2011 Feb 9;11(1):63.

7. Maeda Y, Høyer M, Lundby L, Norton C. Faecal incontinence following radiotherapy for prostate cancer: A systematic review. Radiother Oncol. 2011 Feb;98(2):145-53.

6. Carl J, Nielsen J, Holmberg M, Larsen EH, Fabrin K, Fisker RV Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer. Acta Oncol. 2011 May;50(4):547-54.

5. Persson GF, Nygaard DE, af Rosenschöld PM, Vogelius IR, Josipovic M, Specht L, Korreman SS. Artifacts in conventional computed tomography (CT) and free breathing four-dimensional CT induce uncertainty in gross tumor volume determination Int J Radiat Oncol Biol Phys. 2010 Dec 14.

4. Wiechec E, Wiuf C, Overgaard J, Hansen LL. High Resolution Melting (HRM) analysis for mutation screening of RGSL1, RGS16 and RGS8 in breast cancer Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):397-407.

3. Hoff CM, Hansen HS, Overgaard M, Grau C, Johansen J, Bentzen J, Overgaard J. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy - Results from the randomized DAHANCA 5 study Radiother Oncol. 2011 Jan;98(1):28-33

2. Fenkell L, Assenholt M, Nielsen SK, Haie-Meder C, Pötter R, Lindegaard J, Tanderup K. Parametrial Boost Using Midline Shielding Results in an Unpredictable Dose to Tumor and Organs at Risk in Combined External Beam Radiotherapy and Brachytherapy for Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys. 2010 Aug 26.